ACHC Stock Recent News
ACHC LATEST HEADLINES
ACHC beats Q2 earnings estimates despite lower average length of stay and higher expenses, thanks to increased patient days.
Acadia Healthcare Company, Inc.'s Q2 results showed revenue growth and profitability, but ongoing DOJ/SEC investigations and Medicaid headwinds continue to weigh on sentiment. Despite ACHC undervaluation based on P/S and P/E ratios, I remain cautious due to persistent reputational issues and softness in Medicaid-driven business. Management is focused on growth and expansion, but legal costs, CFO resignation, and policy uncertainty present ongoing risks.
Acadia Healthcare Company, Inc. (NASDAQ:ACHC ) Q2 2025 Earnings Conference Call August 6, 2025 9:00 AM ET Company Participants Christopher Howal Hunter - CEO & Director Heather Dixon - Chief Financial Officer Patrick Thomas Feeley - Senior Vice President of Investor Relations Conference Call Participants Albert J. William Rice - UBS Investment Bank, Research Division Matthew Dale Gillmor - KeyBanc Capital Markets Inc., Research Division Andrew Mok - Barclays Bank PLC, Research Division Philip Chickering - Deutsche Bank AG, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Raj Kumar - Stephens Inc., Research Division Benjamin Whitman Mayo - Leerink Partners LLC, Research Division Ryan M.
Acadia Healthcare (ACHC) came out with quarterly earnings of $0.83 per share, beating the Zacks Consensus Estimate of $0.71 per share. This compares to earnings of $0.91 per share a year ago.
ACHC, BLCO and BBCP have been added to the Zacks Rank #5 (Strong Sell) List on July 30, 2025.
Acadia Healthcare (ACHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
If you purchased or acquired stock in Acadia between February 28, 2020 to October 30, 2024 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
DDD, ACHC and BBCP have been added to the Zacks Rank #5 (Strong Sell) List on July 25, 2025.
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its second quarter 2025 results on Tuesday, August 5, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Wednesday, August 6, 2025. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website. The webcast of the conference call.
ACHC, CNL and RDY have been added to the Zacks Rank #5 (Strong Sell) List on July 18, 2025.